Genpact Limited Stock Performance
| G Stock | USD 45.37 0.09 0.20% |
The company retains a Market Volatility (i.e., Beta) of 0.76, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genpact's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genpact is expected to be smaller as well. At this point, Genpact Limited has a negative expected return of -0.0092%. Please make sure to check out Genpact's maximum drawdown, daily balance of power, relative strength index, as well as the relationship between the skewness and day typical price , to decide if Genpact Limited performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Genpact Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Genpact is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Actual Historical Performance (%)
One Day Return (0.20) | Five Day Return 2.23 | Year To Date Return 5.54 | Ten Year Return 106.13 | All Time Return 170.87 |
Forward Dividend Yield 0.0155 | Payout Ratio | Forward Dividend Rate 0.68 | Dividend Date 2025-09-25 | Ex Dividend Date 2025-06-18 |
1 | Acquisition by James Madden of 7582 shares of Genpact subject to Rule 16b-3 | 05/22/2025 |
2 | Genpact Limited Board Declares Quarterly Cash Dividend G Stock News | 06/06/2025 |
3 | Genpact price target raised by 2 at TD Cowen, heres why G | 06/27/2025 |
| Genpact dividend paid on 30th of June 2025 | 06/30/2025 |
4 | Heres Why You Should Retain Genpact Stock in Your Portfolio Now | 07/02/2025 |
5 | PE Ratio Insights for Genpact | 07/03/2025 |
6 | Genpact Limited Receives Consensus Recommendation of Hold from Brokerages | 07/08/2025 |
7 | Heres Why Genpact is a Strong Value Stock | 07/09/2025 |
8 | Genpact Recognized as One of Americas Best Midsize Companies by TIME | 07/10/2025 |
9 | Genpact Launches AI-Powered AP Suite to Revolutionize Accounts Payable Processes | 07/11/2025 |
10 | Genpact Limited Shares Sold by Victory Capital Management Inc. | 07/16/2025 |
11 | Will Genpact Beat Estimates Again in Its Next Earnings Report | 07/18/2025 |
| Begin Period Cash Flow | 583.7 M | |
| Total Cashflows From Investing Activities | -106 M |
Genpact Relative Risk vs. Return Landscape
If you would invest 4,650 in Genpact Limited on April 20, 2025 and sell it today you would lose (113.00) from holding Genpact Limited or give up 2.43% of portfolio value over 90 days. Genpact Limited is generating negative expected returns and assumes 2.4044% volatility on return distribution over the 90 days horizon. Put is differently, 21% of stocks are less volatile than Genpact, and over 99% of all traded equities are expected to make higher returns on investment over the next 90 days. Expected Return |
| Risk |
Genpact Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genpact's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Genpact Limited, and traders can use it to determine the average amount a Genpact's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0038
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | G |
Estimated Market Risk
| 2.4 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Genpact is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genpact by adding Genpact to a well-diversified portfolio.
Genpact Fundamentals Growth
Genpact Stock prices reflect investors' perceptions of the future prospects and financial health of Genpact, and Genpact fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genpact Stock performance.
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0938 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 8.82 B | ||||
| Shares Outstanding | 174.87 M | ||||
| Price To Earning | 28.59 X | ||||
| Price To Book | 3.23 X | ||||
| Price To Sales | 1.64 X | ||||
| Revenue | 4.77 B | ||||
| Gross Profit | 1.72 B | ||||
| EBITDA | 843.57 M | ||||
| Net Income | 513.67 M | ||||
| Cash And Equivalents | 646.76 M | ||||
| Cash Per Share | 2.53 X | ||||
| Total Debt | 1.45 B | ||||
| Debt To Equity | 1.04 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 14.04 X | ||||
| Cash Flow From Operations | 615.42 M | ||||
| Earnings Per Share | 2.94 X | ||||
| Market Capitalization | 7.93 B | ||||
| Total Asset | 4.99 B | ||||
| Retained Earnings | 1.24 B | ||||
| Working Capital | 1.12 B | ||||
| Current Asset | 1.2 B | ||||
| Current Liabilities | 594.48 M | ||||
About Genpact Performance
By analyzing Genpact's fundamental ratios, stakeholders can gain valuable insights into Genpact's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Genpact has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genpact has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 16.81 | 15.97 | |
| Return On Tangible Assets | 0.16 | 0.10 | |
| Return On Capital Employed | 0.17 | 0.10 | |
| Return On Assets | 0.10 | 0.06 | |
| Return On Equity | 0.21 | 0.13 |
Things to note about Genpact Limited performance evaluation
Checking the ongoing alerts about Genpact for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genpact Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Genpact Limited generated a negative expected return over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors | |
| On 30th of June 2025 Genpact paid $ 0.17 per share dividend to its current shareholders | |
| Latest headline from zacks.com: Will Genpact Beat Estimates Again in Its Next Earnings Report |
- Analyzing Genpact's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genpact's stock is overvalued or undervalued compared to its peers.
- Examining Genpact's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genpact's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genpact's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genpact's stock. These opinions can provide insight into Genpact's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Genpact Stock analysis
When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |